Skip to content
healthcare.dev

Levothyroxine Sodium

NDC 42292-040, levothyroxine sodium, tablet, from Mylan Institutional Inc..

Product NDC
42292-040
Status
Listed
Labeler
Mylan Institutional Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076187
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42292-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE SODIUM175 ug/1

Pharmacologic classes

Thyroxine [CS]; l-Thyroxine [EPC]

Package NDCNDC-11Package
42292-040-2042292004020100 BLISTER PACK in 1 CARTON (42292-040-20) / 1 TABLET in 1 BLISTER PACK (42292-040-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cd69c192-cd3f-47e6-b0a6-c536ffed5c4b
  • NADAC price for package 42292004020

    GET /v1/drugs/nadac/42292004020

Use it

Look up 42292-040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42292-040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42292-040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.